ADAMTS13 and thrombotic thrombocytopenic purpura: The finding that 5% of healthy (non‐TTP) individuals are positive for circulating low‐affinity anti‐ADAMTS‐13 IgG autoantibodies 64 may suggest that administration of preactivated ADAMTS‐13 in other indications should be approached cautiously.